Antiarrhythmic or time bomb? A severe iatrogenic bradyarrhythmia

Antiarrhythmic or time bomb? A severe iatrogenic bradyarrhythmia

We report a case of severe bradyarrythmia with hypotension and extremely large QRS due to proarrhythmic effect of drug combination (amiodarone following infusion of propafenone) for the conversion of Paroxysmal Atrial Fibrillation (PAF) in a 74 year old woman. The authors focus on the important side...

Full description

Bibliographic Details
Main Authors:	S. Matheou, A. Reverzani, F. Dall’Orto, G. Gambarati, G. Chesi
Format:	Article
Language:	English
Published:	PAGEPress Publications 2013-05-01
Series:	Italian Journal of Medicine
Subjects:	Paroxysmal atrial fibrillation Antiarrhythmic Propafenone Amiodarone.
Online Access:	http://www.italjmed.org/index.php/ijm/article/view/351

Similar Items

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

THE PROPANORM EFFICACY IN RAPID RELIEF OF SYMPTOMS OF PAROXYSMAL AURICULAR FIBRILLATION
by: N. N. Borovkov, et al.
Published: (2003-10-01)

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
by: Hesham S. Taha, et al.
Published: (2022-05-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

Antiarrhythmic therapy effects on quality of life among patients with extrasystoles
by: V. L. Doshchitsyn, et al.
Published: (2008-10-01)

Comparative Effectiveness of Aksaritmin and Propafenone in the Prevention of Atrial Fibrillation
by: Husniddin Sh. Kuchkarov, et al.
Published: (2023-06-01)

Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation
by: Takashi Komatsu
Published: (2012-06-01)

EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION
by: O. N. Miller, et al.
Published: (2010-08-01)

Reduced progression of atrial fibrillation in hypertensive patients with long-term treatment of propafenone
by: A. I Tarzimanova, et al.
Published: (2016-06-01)

Amiodarone Versus Propafenone to Treat Atrial Fibrillation after Coronary Artery Bypass Grafting: A Randomized Double Blind Controlled Trial
by: Mohammad Hassan Nemati, et al.
Published: (2016-06-01)

Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
by: Maciej T. Wybraniec, et al.
Published: (2018-10-01)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
by: Meng Geng, et al.
Published: (2020-11-01)

Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation
by: Khava M. Dzaurova, et al.
Published: (2021-09-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

Pharmacological Therapy for Fibrillations
by: Akira Fujiki, MD
Published: (2007-01-01)

Amiodarone treatment investigation on the correlation between the drug sensitivity for paroxysmal atrial fibrillation and gene polymorphism
by: Shuxin Hou, et al.
Published: (2016-01-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
by: Sean P. Gaine, et al.
Published: (2023-04-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Systematic review and cost-effectiveness evaluation of ‘pill-in-the-pocket’ strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy
by: C Martin Saborido, et al.
Published: (2010-06-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
by: Koichiro Kumagai, MD, et al.
Published: (2011-01-01)

EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER)
by: T. A. Istomina, et al.
Published: (2016-01-01)

Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
by: Yu. A. Bunin, et al.
Published: (2005-12-01)

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
by: Jonathan G. Tardos, et al.
Published: (2021-03-01)

Predictors of class IC antiarrhythmic drugs efficacy in patients with paroxysmal form of atrial fibrillation
by: Manizha A. Khalikova, et al.
Published: (2023-10-01)

Amiodarone (cordarone) efficiency in atrial extrasystoles
by: D I Reingardene, et al.
Published: (2004-06-01)

SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
by: N P Dorofeeva, et al.
Published: (2017-03-01)

ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
by: T. A. Rybakova, et al.
Published: (2018-08-01)

THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS
by: Yu. A. Bunin
Published: (2016-01-01)

Results of propafenone use in early postoperative period after pulmonary veins catheter radiofrequency isolation for prevention of early atrial tachyarrhythmias
by: A. V Tarasov, et al.
Published: (2015-06-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY
by: R. D. Kurbanov, et al.
Published: (2015-12-01)

Efficacy of Long-term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation —Analysis Based on Time of Onset—
by: Takashi Komatsu, MD, et al.
Published: (2006-01-01)

Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF) – Report on antiarrhythmic drug therapy
by: Yuji Murakawa, MD, et al.
Published: (2014-10-01)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
by: Inseok Hwang, et al.
Published: (2021-05-01)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
by: Inseok Hwang, et al.
Published: (2022-12-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases
by: Czarnywojtek A, et al.
Published: (2016-04-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)